Pembrolizumab After Radiation Therapy and Chemotherapy in Limited Stage Small Cell Lung Cancer

Clinical trial NCT06140407 · TERMINATED

Trial details

NCT number: NCT06140407
Sponsor: Vanderbilt-Ingram Cancer Center
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Limited Stage Lung Small Cell Carcinoma Stage I Lung Cancer Stage II Lung Cancer Stage III Lung Cancer

Start date: 2024-02-14
Primary completion: 2025-05-27
Enrollment: 1

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.